Portland-based nonprofit CymaSpace has received a $90,000 grant from the National Endowment for the Arts to fund a year-long study on cochlear implant programming for music perception and multisensory listening, aiming to develop a K-12 STEAM curriculum for Deaf and hard-of-hearing students.
A new fMRI acquisition method developed at the University of North Carolina reduces peak scan noise from levels exceeding 120 decibels.
The dual-sensing ear canal probe technology is inspired by how spiders send sound through their webs.
Israeli and US researchers have identified a biological mechanism that prompts supporting cells in the inner ear to regenerate into sensory hair cells.
Read More
The biotech secures improved royalty terms on its two lead hearing loss programs, CIL001 and CIL003, while Sanofi takes a minority stake in the company.
Read More
A new study published in PLOS One offers what researchers say is the most evidence-supported explanation yet for “The Hum” — an unexplained low-frequency droning reported by people around the world.
Read More
The ProHear Study found that the drug candidate Bimokalner produced a clinically meaningful reduction in pure-tone audiometry threshold shifts in testicular cancer patients who developed cisplatin-induced ototoxicity.
Read More
The $400,000 prize, administered by the Broad Institute, recognizes the researchers whose complementary work turned the cochlear implant into a viable clinical option now used by more than one million people worldwide.
Read More
As chair, Amlani will lead efforts to expand the department’s educational, research, and clinical impact.
Read More
Sensorion is focusing on SENS-601 targeting GJB2 mutations, while discontinuing development of its OTOF-targeting program, SENS-501.
Read More
New research suggests hormonal fluctuations across a person’s lifespan produce measurably different auditory outcomes in men and women — with implications for how clinicians approach diagnosis and management of hearing loss.
Read More
The system aims to provide insight into sensory hair cell development and potential pathways for regeneration.
Read More
A University of Michigan researcher has developed 3D-printed acoustic tiles that can be customized to control sound reflection and enhance communication.
Read More
If approved, Regeneron’s Otarmeni will be the first gene therapy for OTOF-related hearing loss in the European Union.
Read More
The students were recognized for research on surgical barriers, sentence recognition, and Medicare qualification criteria.
Read More
A 3D-printed earplug design aims to improve protection and user comfort by canceling specific sound waves within the ear canal.
Read More
The company plans a clinical trial for its CIL001 drug candidate at Massachusetts General Hospital and will triple preclinical capacity through its partnership with CBSET.
Read More
A multicenter study found a one-time treatment targeting the OTOF gene restored hearing in most participants, with effects lasting up to 2.5 years.
Read More